Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights
Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights
通過分析師的洞見，剖析4D分子治療技術的各個層面。
In the preceding three months, 5 analysts have released ratings for 4D Molecular Therapeutics (NASDAQ:FDMT), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師發佈了對4d分子治療(納斯達克:FDMT)的評級，提供了從看好到看淡的廣泛觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $38.0, a high estimate of $40.00, and a low estimate of $36.00. Highlighting a 10.8% decrease, the current average has fallen from the previous average price target of $42.60.
分析師評估的12個月目標價揭示了進一步的見解，平均目標價爲38.0美元，最高估值爲40.00美元，最低估值爲36.00美元。突顯出平均目標價已經從先前的42.60美元下降了10.8%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The standing of 4D Molecular Therapeutics among financial experts...
通過深入探索最近...
登入免費觀看全文
登入/註冊